Month: July 2017
So, it’s been a ridiculously long time since I posted and for that, I am sorry. I meant to update in May as a one-year anniversary of my first round of treatment and I was still slogging through some side…
We have exciting news in regards to Peptide Receptor Radionuclide Therapy (PRRT) therapy in the United States. Advanced Accelerator Applications is currently pursuing marketing approval for 177Lu-DOTA0-Tyr3-Octreotate (Lutathera). Considering that Phase III NETTER-1 clinical trial recruitment has been completed, this expanded…
Hey, good looking, have you been noticing subtle changes with your skin? You might want to get your cute booty to the skin doctor ASAP. Patients living with neuroendocrine cancers including carcinoid are frequently familiar with two of the classic symptoms…
